Product Catalog

LiraglutideSpecifications & Batch COA

GLP-1 receptor agonist with C16 fatty acid conjugation for extended half-life. Proven weight management therapy.

KERUIHK-0109Liraglutide product vial
Lyophilized PowderProduct image
Weight Loss & Metabolic

Liraglutide

GMPKERUIHK-0109

GLP-1 receptor agonist with C16 fatty acid conjugation for extended half-life. Proven weight management therapy.

Product Specifications

CAS Number
204656-20-2
Catalog Purity
≥99.35%
Form
Lyophilized Powder
Catalog Grade
GMP
View batch documentation

Product Details

Liraglutide specifications

Use the product name, catalog reference and available specifications below when discussing your requirements with our team.

Product
Liraglutide
Catalog reference
KERUIHK-0109
CAS number
204656-20-2
Category
Weight Loss & Metabolic
Physical form
Lyophilized Powder

Latest reported batch: Liraglutide

Batch PB-2026-LIR-6154 · Oct 3, 2026

Reported appearance
White lyophilized powder
Reported molecular weight / identity
3751.18 Da
Analytical method
RP-HPLC / ESI-MS

Reported analytical results

HPLC Purity
99.23%Report specification: ≥99.0%
Molecular Weight (MS)
3751.18 DaReport specification: 3751.20 ± 0.5 Da
Amino Acid Analysis
ConformsReport specification: Conforms to sequence
Endotoxin (LAL)
0.27 EU/mgReport specification: < 1.0 EU/mg
Show 5 more test results
Sterility (USP <71>)
No growth observedReport specification: No evidence of microbial growth
Residual Solvents
< ICH Q3C limitsReport specification: ICH Q3C Class 2
Water Content (KF)
5.10%Report specification: ≤ 8.0%
Fatty Acid Conjugation
ConformsReport specification: C16 fatty acid confirmed
Peptide Content (AAA)
95.85%Report specification: ≥95.0%
Source COA: PB-2026-LIR-6154-R20261003
Explore this category

Batch Documentation

Certificates of Analysis

Open a batch below to view its full report in our COA library, including available analytical attachments and PDF download.

PB-2026-LIR-6154Report product: LiraglutideOct 3, 2026 · Reported purity: 99.23%View this batch COA
PB-2026-LIR-6154Report product: LiraglutideAug 22, 2026 · Reported purity: 99.3%View this batch COA
PB-2026-LIR-0495Report product: LiraglutideJul 23, 2026 · Reported purity: 99.1%View this batch COA
Show 3 earlier reports
PB-2026-LIR-0381Report product: LiraglutideApr 17, 2026 · Reported purity: 99.3%View this batch COA
PB-2025-LIR-0302Report product: LiraglutideDec 02, 2025 · Reported purity: 99.1%View this batch COA
PB-2025-LIR-0218Report product: LiraglutideAug 15, 2025 · Reported purity: 99.0%View this batch COA

Product Inquiry

Request a Liraglutide quotation

We synthesize any sequence at any scale — from milligram research quantities to multi-kilogram commercial batches. OEM, private label, and GMP manufacturing available. Response within 24 hours.

Discuss your requirements
Back to all products